1 May 2023 false Taxfiler 2024.6 14510699business:PrivateLimitedCompanyLtd2023-05-012024-04-30 145106992023-04-30 145106992023-05-012024-04-30 14510699business:AuditExemptWithAccountantsReport2023-05-012024-04-30 14510699business:FilletedAccounts2023-05-012024-04-30 145106992024-04-30 14510699business:Director12023-05-012024-04-30 14510699business:Director22023-05-012024-04-30 14510699business:Director32023-05-012024-04-30 14510699business:RegisteredOffice2023-05-012024-04-30 14510699core:WithinOneYear2024-04-30 14510699core:AfterOneYear2024-04-30 14510699countries:EnglandWales2023-05-012024-04-30 14510699business:Micro-entities2023-05-012024-04-30 iso4217:GBP xbrli:pure
Company Registration No. 14510699 (England and Wales)
Quadpharma Limited Unaudited accounts for the year ended 30 April 2024
Quadpharma Limited Annual report and unaudited accounts for the year ended 30 April 2024
CONTENTS
PAGE
- 2 -
Quadpharma Limited Company Information for the year ended 30 April 2024
Directors
Guo How Chin Seng Chun Kok Wing Foo Yap
Company Number
14510699 (England and Wales)
Registered Office
69 Dart Avenue Exeter Devon EX2 7TX England
Accountants
K3 Accountants Limited Barnwood Trampers Lane North Boarhunt Hampshire PO17 6DG
- 3 -
Quadpharma Limited Accountants' report
Accountants' report to the board of directors of Quadpharma Limited on the preparation of the unaudited statutory accounts for the year ended 30 April 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Quadpharma Limited for the year ended 30 April 2024 as set out on pages 5 - 5 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Quadpharma Limited, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Quadpharma Limited and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Quadpharma Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Quadpharma Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Quadpharma Limited. You consider that Quadpharma Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Quadpharma Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
K3 Accountants Limited Barnwood Trampers Lane North Boarhunt Hampshire PO17 6DG 18 March 2025
- 4 -
Quadpharma Limited Statement of Financial Position as at 30 April 2024
2024 
£ 
Fixed assets
460,418 
Current assets
295,430 
Prepayments and accrued income
20,000 
Creditors: amounts falling due within one year
(288,501)
Net current assets
26,929 
Total assets less current liabilities
487,347 
Creditors: amounts falling due after more than one year
(443,431)
Accruals and deferred income
20,561 
Net assets
64,477 
Capital and reserves
64,477 
NOTES TO THE ACCOUNTS
1 Statutory information
Quadpharma Limited is a private company, limited by shares, registered in England and Wales, registration number 14510699. The registered office is 69 Dart Avenue, Exeter, Devon, EX2 7TX, England.
2 Average number of employees
During the year the average number of employees was 6.
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 19 March 2025
Seng Chun Kok Director Company Registration No. 14510699
- 5 -